Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cystic fibrosis.

Felix Ratjen1, Gerd Döring

  • 1Department of Paediatrics, University of Essen, Essen, Germany. f.ratjen@uni-essen.de

Lancet (London, England)
|February 28, 2003
PubMed
Summary
This summary is machine-generated.

Cystic fibrosis, a common genetic disorder, involves a defective CFTR gene. Advances in understanding and symptomatic treatments have increased patient life expectancy, though gene therapy remains a challenge.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in children ≥2 years with cystic fibrosis: 96-week interim results from a phase 3 open-label extension study.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026
Same author

Post-infectious bronchiolitis obliterans in children: pathogenesis, treatment strategies, and future directions.

Current opinion in pediatrics·2026
Same author

Automated Ultrashort Echo Time (UTE) MRI Low Signal Volume Analysis in Stable Pediatric Cystic Fibrosis and After Elexacaftor/Tezacaftor/Ivacaftor Therapy.

Journal of magnetic resonance imaging : JMRI·2026
Same author

Real-world impact of elexacaftor/tezacaftor/ivacaftor on health-related quality of life in adults with cystic fibrosis: A 12-month multicenter cohort study.

Respiratory medicine·2026
Same author

The Impact of Nutritional Status on Lung Function Trajectories in Pediatric Patients With Primary Ciliary Dyskinesia.

Pediatric pulmonology·2026
Same author

Treatment with elexacaftor/tezacaftor/ivacaftor does not alter SpiroNose-derived electronic breath profiles in children with cystic fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026

Area of Science:

  • Genetics
  • Pulmonology
  • Biomedical Research

Background:

  • Cystic fibrosis is a prevalent autosomal recessive disorder.
  • The discovery of the cystic fibrosis transmembrane conductance regulator (CFTR) gene has advanced understanding of its pathophysiology and diagnosis.
  • Despite progress, the disease's complexity and challenges in gene replacement therapy remain.

Purpose of the Study:

  • To summarize recent advances in understanding cystic fibrosis.
  • To review current treatment strategies for cystic fibrosis, with a focus on pulmonary disease.
  • To highlight the complexity of cystic fibrosis and the ongoing challenges in therapeutic development.

Main Methods:

  • Literature review of recent studies on cystic fibrosis.
  • Analysis of advancements in diagnostic tools and understanding of CFTR gene function.

Related Experiment Videos

  • Evaluation of current and emerging treatment strategies for pulmonary manifestations.

    • Main Results:

    • Significant improvements in understanding cystic fibrosis pathophysiology and diagnosis.
    • Increased life expectancy due to enhanced symptomatic treatment strategies.
    • Gene replacement therapy faces hurdles in effective cell targeting.

    Conclusions:

    • Advances in cystic fibrosis research have improved patient outcomes.
    • Pulmonary disease remains the primary cause of morbidity and mortality.
    • Further research is needed for effective gene therapies and comprehensive management.